Amoeba: departure of CEO Fabrice Plasson – 12/15/2023 at 6:10 p.m.


(AOF) – Amoeba announces that a separation of the mandates of Chairman of the Board of Directors and General Director was voted by the Board of Directors on December 14, 2023, leading to the cessation of the mandates of Chairman of the Board of Directors and of Managing Director of Fabrice Plasson. Benoit Villers, Executive Board Member at Nice & Green SA, was appointed director and Chairman of the Board of Directors, while the function of Managing Director was entrusted to Jean-François Doucet, previously Deputy Managing Director.

This pre-commercial industrial biotech specializes in the treatment of microbiological risks. At the same time, it announced the postponement of work on its Biocontrol factory in Cavaillon, “pending additional financing”.

AOF – LEARN MORE

Learn more about the chemicals sector

Nothing is going well for German chemistry

German chemicals, very dependent on Russian gas, are in difficulty. Following sluggish sales in the automotive sector and falling demand in construction, production is down 8.5% in 2022, with overall turnover down 1.6% to 63.1 Billions of Euro’s. Specialty chemistry is doing better. On the other hand, the rate of utilization of production capacities in basic chemicals has slowed significantly to reach less than 80%. The third German industrial sector is tempted by relocation to the United States, where energy costs are much lower. With the Inflation Reduction Act, the United States has established an environment appropriate to current challenges.



Source link -86